It is a pharma private limited company based in Tumkur, Karnataka, India, established in 2019.
2019 | Tumkur, Karnataka, India | ActiveLyskamm Pharmaceutical Private Limited, a active private limited company, was established on 01 May 2019 in Tumkur, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24300KA2019PTC123954. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
Its leadership includes Ved Prakash Srivastava (Director), Divya Srivastava (Director), Jyoti Srivastav (Director). Past directors included Ved Prakash Srivastava, Divya Srivastava, Priyam Srivastava. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 43 Mathrushree Building V.S.S.N. Opp Bidare At Post Chelur Hobli Gubbi Taluk, Tumkur, Karnataka, 572117.
U24300KA2019PTC123954
123954
01 May 2019
₹1.00 M
₹0.15 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Lyskamm Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ved Prakash Srivastava | Director | 25 Oct 2023 | Current |
| Divya Srivastava | Director | 25 Oct 2023 | Current |
| Jyoti Srivastav | Director | 01 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2021 | Past |
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lyskamm Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 573.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lyskamm Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lyskamm Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lyskamm Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lyskamm Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lyskamm Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Lyskamm Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on Ved Prakash Srivastava was appointed as a Director was appointed as a Director on 25 Oct 2023 & has been associated with this company since 2 years 2 months . was documented.
The activity Divya Srivastava was appointed as a Director was appointed as a Director on 25 Oct 2023 & has been associated with this company since 2 years 2 months . was completed.
The activity Jyoti Srivastav was appointed as a Director was appointed as a Director on 01 May 2019 & has been associated with this company since 6 years 7 months . was completed.
The activity Lyskamm Pharmaceutical Private Limited was registered on 01 May 2019 with Roc Bangalore & aged 6 years 7 months as per MCA records. was completed.
The CIN of Lyskamm Pharmaceutical Private Limited is U24300KA2019PTC123954.
Lyskamm Pharmaceutical Private Limited is headquartered at No 43 Mathrushree Building V.S.S.N. Opp Bidare At Post Chelur Hobli Gubbi Taluk, Tumkur, Karnataka, 572117.
Lyskamm Pharmaceutical Private Limited was incorporated on 01 May 2019.
The current directors of Lyskamm Pharmaceutical Private Limited are
The primary industry of Lyskamm Pharmaceutical Private Limited is Pharma.
Lyskamm Pharmaceutical Private Limited is unlisted.
The authorized capital of Lyskamm Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX